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KEY MESSAGE
This study reaffirms the usefulness of endometrial thickness as a potential prognostic tool for live birth rates
and neonatal birthweight in contemporary IVF, particularly when considered together with other ovarian stimu-
lation monitoring methods, such as the late-follicular endocrine profile.
A B S T R A C T
The evaluation of endometrial thickness (EMT) is still part of standard cycle monitoring during IVF, despite the lack of robust evidence of any value of
this measurement to predict little revalidation in contemporary medical practice; other tools, however, such as endocrine profile monitoring, have become
increasingly popular. The aim of this study was to reassess whether EMT affects the outcome of a fresh embryo transfer in modern-day medicine,
using a retrospective, single-centre cohort of 3350 IVF cycles (2827 women) carried out between 2010 and 2014. In the multivariate regression analysis,
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EMT was non-linearly associated with live birth, with live birth rates being the lowest with an EMT less than 7.0 mm (21.6%; P < 0.001) and then between
7.0 mm and 9.0 mm (30.2%; P = 0.008). An EMT less than 7.0 mm was also associated with a decrease in neonatal birthweight z-scores (−0.40; 95% CI
−0.69 to −0.12). In conclusion, these results reaffirm the use of EMT as a potential prognostic tool for live birth rates and neonatal birthweight in con-
temporary IVF, namely when considered together with other ovarian stimulation monitoring methods, such as the late-follicular endocrine profile.
© 2018 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.
Introduction
Over the years, much has been published on potential sonographic
markers for endometrial receptivity. Although it remains a contro-
versial issue, endometrial thickness (EMT) is the most widely used
prognostic factor for endometrial receptivity during assisted repro-
ductive techniques (Kasius et al., 2014).
Several mechanisms are responsible for modifications caused to
the morphology and histology of the endometrium before embryo im-
plantation. Specifically, previous studies have shown that endometrial
proliferation is dependent on reproductive age, hormonal levels of
oestradiol and the expression of endometrial receptors (Paulson, 2011;
Zhang et al., 2005).
Debate on the predictive value measuring EMT before adminis-
tering HCG for ovulation triggering in assisted reproduction techniques
is ongoing. Some investigators have shown a linear correlation between
pregnancy rates and EMT (Al-Ghamdi et al., 2008; Chen et al., 2010;
Richter et al., 2007; Rinaldi et al., 1996); however, others have posited
that pregnancy rates may even decline above a thickness of 14 mm
(Weissman et al., 1999), after which miscarriage rates may in-
crease. Moreover, in a retrospective study (Lamanna et al., 2008)
including 606 women undergoing a long-agonist protocol, the inves-
tigators reported a parabolic trend in pregnancy rate across EMT
categories (with lower pregnancy rate in EMT extremes below 8 mm
and above 14 mm, respectively). In 2014, a meta-analysis of 22 studies
concluded that the measurement of EMT was a valuable predictor for
clinical pregnancy, with lower clinical pregnancy rates below the fre-
quently mentioned cut-off of 7 mm, which progressively increased until
10 mm of EMT (Kasius et al., 2014). On the basis of these results, one
could conclude that a thick endometrium may not necessarily predict
pregnancy but, conversely, a thin endometrium may be associated
with lower pregnancy rates, possibly owing to a thinner functional layer
that exposes the embryo to the higher oxygen concentrations of the
blood from the spiral arteries during implantation (Casper, 2011).
Adequate endometrial development seems to be of paramount im-
portance for placentation, given that previous studies have shown an
association between abnormal glandular or vascular development and
defective-placentation disorders, including placental abruption, low
birth weight (LBW), fetal growth restriction, pregnancy-related hy-
pertensive disorders and pregnancy loss (Palatnik et al., 2016; Pelinck
et al., 2010a, 2010b; Rombauts et al., 2014; Toal et al., 2007). Most
of the previously mentioned studies relate EMT to pregnancy rate with
no mention of the potential effect on neonatal morbidity (Holden et al.,
2017; Ma et al., 2017; Yuan et al., 2016), despite the common knowl-
edge that assisted reproduction techniques are associated with
preterm birth and LBW (Declercq et al., 2015; Jackson et al., 2004;
Poikkeus et al., 2007; Schieve et al., 2002). The contributing factors
of LBW after assisted reproduction techniques are immense, with little
agreement on the main underlying causes. Multiple studies have
pointed to either certain relevant baseline characteristics of the popu-
lation seeking assisted reproduction techniques or specificities in the
stimulation protocols and laboratory procedures (Bower and Hansen,
2005; Doyle et al., 1992; Helmerhorst et al., 2004; Jackson et al., 2004;
Ludwig et al., 2006; Putterman et al., 2003; Schieve et al., 2002; Wang
et al., 2005). Specifically, subfertility itself is a risk factor for LBW
(Axmon and Hagmar, 2005; Basso and Baird, 2003; Bergh et al., 1999;
Draper et al., 1999; Pandian et al., 2001), with conflicting results on
whether specific causes of infertility pose a higher risk than others
(Doyle et al., 1992; Wang et al., 2005). Some evidence also suggests
a detrimental effect of the hyperestrogenic milieu on neonatal out-
comes, given that neonates resulting from minimal-stimulation IVF
may have higher birth weights compared with conventional IVF new-
borns (Pelinck et al., 2010a, 2010b). Furthermore, others have
associated EMT less than 10 mm with an increased risk of adverse
perinatal outcomes, including preterm delivery, LBW and fetal demise
(Chung et al., 2006), an association which may be explained by a
reduced selective capacity of thinner endometria (Oron et al., 2016).
Monitoring of both the endometrial and ovarian responses to
ovarian stimulation with transvaginal ultrasound has become an im-
portant predictor of the success of assisted reproduction techniques
(McWilliams and Frattarelli, 2007). Also, many agree that a concomi-
tant hormonal assessment may also be beneficial in predicting assisted
reproduction technique outcome (Hardiman et al., 1990; Loumaye et al.,
1997; Rizk and Smitz, 1992), although it is not universally applied
(Murad, 1998; Vandekerckhove et al., 2014) because supraphysiologic
hormone levels during ovarian stimulation seem to be the underly-
ing mechanism causing a so-called ‘endometrium-embryo asynchrony’
(Al-Azemi et al., 2012; Kyrou et al., 2009; Roque et al., 2013; Shapiro
et al., 2011). More specifically, it has been reported that abnormal
serum progesterone levels may be associated with lower ongoing preg-
nancy rate and live birth rates (Bosch et al., 2010; Kolibianakis et al.,
2002; Santos-Ribeiro et al., 2014).
The main aim of this study was to estimate the predictive value
of EMT in live birth and the neonatal outcomes of fresh embryo trans-
fers in contemporary medicine, accounting specifically for the
endocrine profile of the patient during the late-follicular phase.
Materials and methods
Study design
This retrospective, single-centre, cohort study included assisted re-
production technique treatment cycles carried out at the Universitair
Ziekenhuis, Brussels, between January 2010 and December 2014. Only
cycles in which patients underwent a gonadotrophin-releasing hormone
(GnRH) antagonist down-regulated stimulation protocol followed by
a fresh embryo transfer were included. To minimize confounding
derived from women with a baseline poor prognosis, we excluded
cycles in women aged 40 years or older and managed natural cycles.
The exclusion criteria also included those who underwent cycles with
known uterine abnormalities (including uterine malformations and
intrauterine disease diagnosed during ultrasound or a preceding
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hysteroscopy, such as Asherman’s syndrome, endometrial polyps, sub-
mucosal myomas) and the planned use of either surgically retrieved
sperm, donor oocytes, in-vitro maturation or preimplantation genetic
diagnosis. Approval and waiver of written informed consent to re-
trieve and analyse the data was obtained from the Ethical Committee
of Universitair Ziekenhuis Brussel (dated 17 May 2017, reference
number 1432017369).
Assisted reproduction technique protocol
Ovarian stimulation was started on day 2 of the menstrual cycle with
50–450 IU/day of recombinant FSH (rFSH: Gonal-F®, Merck Phar-
maceuticals, Darmstad, Germany; Puregon®, Merck Sharp & Dohme,
Whitehouse Station, NJ, USA or Elonva®, Merck Sharp & Dohme) or
highly purified human menopausal gonadotrophin (HP-HMG;
Menopur®, Ferring Pharmaceuticals, St. Prex, Switzerland). Pitu-
itary down-regulation was achieved with a daily 0.25 mg GnRH
antagonist injection of either cetrorelix (Cetrotide®, Merck Pharma-
ceuticals) or ganirelix (Orgalutran®, Merck Sharp & Dohme) starting
on day 7 of the menstrual cycle.
Cycle monitoring was carried out with periodic transvaginal ul-
trasound and serum oestradiol and progesterone concentration
assessments. When at least three follicles measuring 17 mm mean
diameter or over were visible, triggering of final oocyte maturation
was carried out using either highly purified urinary HCG (5000 UI or
10 000 UI, according to patient weight; Pregnyl®, Merck Sharp &
Dohme) or 250 UI of recombinant HCG (Ovitrelle®, Merck Pharma-
ceuticals). Oocyte retrieval was carried out about 36 h after HCG
administration and followed by fertilization by either conventional IVF
or intracytoplasmic sperm injection (ICSI).
Main outcomes measures
On the day of, or day before, ovulation triggering, EMT was mea-
sured in millimeters. We considered the EMT as the maximal anterior–
posterior distance between both endometrial layers about 1 cm from
the uterine fundus, subtracting the thickness of intrauterine fluid in
the unlikely event that such was detected.
We considered a clinical pregnancy to be one or more gesta-
tional sacs diagnosed by ultrasonographic visualization, with any
pregnancy loss after this period being defined as a clinical miscar-
riage. Live birth was defined as the number of deliveries that resulted
in at least one live born neonate beyond 24 weeks of gestational age,
with twin or higher order pregnancies being considered only once
(Zegers-Hochschild et al, 2009).
Factors potentially associated with endometrial thickness
The following variables were assessed as potential predictors of EMT:
female age, body mass index, total dose of exogenous FSH/highly
purified human menopausal gonadotrophin, duration of ovarian
stimulation, and late-follicular phase oestradiol and progesterone.
To avoid bias by assuming that the relationship between these con-
tinuous predictors and EMT was linear, the best-fitting fractional
polynomial of each of these variables was compared against their linear
function to assess which one better described their association with
EMT. This recognized statistical technique is a widely used method
that allows an accurate assessment of what type of relationship better
explains the association between a continuous variable and any given
continuous or dichotomous outcome (Sauerbrei et al., 2006; Sunkara
et al., 2011; Templeton et al., 1996).
Evaluation of the relationship between endometrial thickness,
live birth and neonatal outcomes
In the present study, EMT was the main exposure variable for live birth.
We are aware that the categorization of continuous variables may be
of limited value in determining the real effect of a predictor. This is
because it simultaneously assumes that values in different inter-
vals have different effects even if close to each other, and that values
on the extremes, but within the same interval group, have the same
effect. Therefore, our main approach was to assess the relationship
of EMT as a continuous variable comparing the best fitting frac-
tional polynomial against the linear function (model 1). Nonetheless,
to facilitate the application of the results into everyday clinical prac-
tice, EMT was also assigned to the following regular 2-mm-intervalled
categories: less than 7.0 mm, 7.0–8.9 mm, 9.0–10.9 mm, 11.0–
12.9 mm and 13.0 mm or over (model 2). These intervals were chosen
to provide equal intervals as close as possible to the different lower
and upper threshold values used across previous studies (Holden et al.,
2017; Kasius et al., 2014; Lamanna et al., 2008; Richter et al., 2007).
When assessing the effect of EMT on live birth, we considered the
following variables as potential confounders: female age, body mass
index (BMI), rank of IVF–ICSI treatment cycle attempt, number of
useable embryos (transferred and cryopreserved), number of embryos
transferred (single versus multiple), embryo stage at transfer (cleav-
age day-3 versus blastocyst day-5), quality of the best embryo
transferred (1, 2 or 3–4, sub-classified as detailed previously (Montagut
et al., 2016)) and both late-follicular phase oestradiol and proges-
terone levels (determined on the day or day before ovulation triggering).
We also assessed the effect of EMT on neonatal outcomes, spe-
cifically gestational age at delivery, preterm birth (<37 weeks), birth
weight and LBW (<2500 g). Given the non-linear progression of fetal
growth as pregnancy develops, and differences according to fetal sex
(Hadlock et al., 1985), the recorded birth weights were standardized
using z-scores (Niklasson and Albertsson-Wikland, 2008). The z-scores
indicate how many standard deviations an observation was above or
below the reference population mean, accounting for gestational age
and neonatal sex. Furthermore, given the significant influence of mul-
tiple pregnancies on fetal development, only singleton live births were
evaluated. For this analysis, we considered the following variables
as potential confounders: female age, BMI, parity (nulliparous versus
multiparous), and the late-follicular phase oestradiol and proges-
terone levels.
Other considerations of the statistical analysis
Baseline characteristics were compared between the above-mentioned
EMT categories for model 2, with categorical variables presented with
relative frequency (%). Continuous variables were presented as means
(SD) or medians (interquartile range) according to the normality of
the distribution. Comparisons were made using generalized estimat-
ing equation (GEE) regression analysis, to account for the possibility
of clustering of more than one cycle deriving from the same couple.
The predictors for EMT, live birth and neonatal outcomes were
determined using univariable and multivariable GEE regression analy-
sis, adjusting for the potential confounders mentioned previously. In
model 2, the median values of each variable in the sample set were
chosen as reference values.
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P < 0.05 was considered to be significant. Stata Software version
13.1 (StataCorp, College Station, Texas, USA) was used for statisti-
cal analysis.
Results
Patient baseline demographics and general characteristics of
the treatment cycle
A total of 3350 cycles (carried out in 2827 women) were included in
the analysis. The baseline demographics and main cycle character-
istics according to EMT are presented in Table 1 and Table 2. The
distribution of the following characteristics before oocyte retrieval
varied significantly among the many EMT categories: BMI (P < 0.001),
total dose of exogenous gonadotrophins (P = 0.003), duration of ovarian
stimulation (P = 0.017) and late-follicular oestradiol (P = 0.001). Con-
versely, the number of oocytes retrieved, useable embryos produced
and characteristics of the embryo(s) transferred (specifically, number,
developmental stage and quality) did not vary significantly among the
groups.
Factors associated with endometrial thickness
The results of the multivariable regression models for the predic-
tion of EMT are presented in Supplementary Table S1. Increases in
BMI were associated with a modest increase in EMT (P < 0.001);
however, increases in late-follicular progesterone were inversely
related with EMT (P = 0.007). Specifically, each 1 kg/m2 increase in
BMI was linearly associated with a 0.07 mm increase in EMT, and each
1.0 ng/ml increase in progesterone was linearly associated with a
0.25 mm decrease in EMT.
The duration of ovarian stimulation and late-follicular oestradiol
were independently and non-linearly associated with an increase in
EMT (P = 0.001 and P < 0.001, respectively) (Figure 1). Their effect
on EMT, however, were also modest and mostly visible only in the
lower limits of these variables. Specifically, the mean EMT seemed
to stabilize once a minimum of 7 days of ovarian stimulation and con-
centration of 1000 pg/ml of oestradiol were reached.
The effect of endometrial thickness on live birth
To assess the effect of EMT on live birth, two logistic regression models
were conducted, differing only in how the continuous variables were
introduced into the model (either as fractional polynomials [model
1] or ordinal categories [model 2], respectively. The details of the mul-
tivariable regression models are presented in Supplementary
Table S2. A shown in Figure 2, EMT was a non-linear significant pre-
dictor of live birth, affecting live birth rates. Furthermore, when
specifically using the EMT category that included the median EMT of
the sample set (9.6 mm) as the reference value (the 9.0–10.9 mm cat-
egory from model 2), EMTs less than 7.0 mm (P < 0.001) and between
7.0 and 8.9 mm (P = 0.008) were both associated with a significant
decrease in live birth rates (Supplementary Table S2 and
Supplementary Figure S1B).
The collective effect of EMT and the late-follicular endocrine profile
on live birth is presented in Figure 3. Late-follicular-phase oestradiol
had little effect on live birth rates; however, the increase of proges-
terone contributed significantly (P < 0.039) to a reduction in live birth
rates within the same EMT measurement. For instance, for a fixed
EMT of 10.0 mm, increasing late-follicular progesterone levels of
1.0 ng/ml, 1.5 ng/ml or 2.0 ng/ml were associated with decreasing
live birth rates of 34%, 30% and 27%, respectively.
Endometrial thickness and neonatal outcomes
The multivariable EMT regression estimates for gestational age,
preterm birth, birth weight z-score and LBW (n = 939) are pre-
sented in Table 3. Although the risk of LBW seemed unaltered by EMT
in both models, birth weight z-scores varied significantly (P = 0.017)
according to EMT (Figure 4). Conversely, gestational age and the risk
of preterm birth seemed to be unaffected by EMT.












Basic female and treatment cycle characteristics
Female age (years)
Median (IQR) 33 (31–36) 32 (29–36) 33 (30–36) 33 (30–36) 33 (29–36) NS
BMI (Kg/m2)
Median (IQR) 22.5 (20.4–26.4) 22.8 (20.6–26.1) 23.4 (21.2–27.3) 23.9 (21.3–28.6) 25.3 (22.0–29.1) <0.001
Rank of reatment cycle attempt
Median (IQR) 2 (1–4) 2 (1–5) 2 (1–5) 2 (1–5) 2 (1–7) NS
Ovarian stimulation and late-follicular phase endocrine profile
Total dose of exogenous gonadotropins (IU)
Median (IQR) 1500 (1200–2013) 1600 (1200–2000) 1575 (1200–2000) 1600 (1218–2088) 1688 (1350–2200) 0.003
Duration of ovarian stimulation (days)
Median (IQR) 9 (8–11) 9 (8–11) 9 (8–11) 10 (9–11) 10 (9–11) 0017
Late-follicular phase oestradiol (pg/ml)
Median (IQR) 1432 (912–2065) 1493 (1070–2090) 1563 (1141–2153) 1498 (1126–2039) 1649 (1203–2326) 0.001
Late-follicular phase progesterone (ng/ml)
Median (IQR) 0.9 (0.6–1.2) 0.9 (0.6–1.2) 0.8 (0.6–1.1) 0.8 (0.6–1.1) 0.8 (0.6–1.1) NS
a Comparisons among groups of endometrial thickness made using univariable regression analysis accounting for the clustering of cycles undertaken by the
same women.
IQR, interquartile range; NS, non-significant.
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Discussion
Despite significant advancements in the fields of ultrasonography
(Singh et al., 2011; Wang et al., 2010; Zhang et al., 2016), immunol-
ogy (Seshadri and Sunkara, 2014) and molecular diagnostics (Koot
et al., 2016; Ruiz-Alonso et al., 2013), the potential benefit of these
novel approaches are yet to be confirmed, leaving most physicians
with only the measurement of EMT during ovarian stimulation to aid
in the decision of whether or not to carry out a fresh embryo trans-
fer. The main aim of the present study was to investigate whether
EMT measurement still plays a role in modern-day medicine. To that
extent, our results provide renewed evidence that EMT may affect live
birth rates and neonatal outcomes.
In their meta-analysis, Kasius et al. (2014) concluded that the fre-
quently reported cut-off of 7 mm only occurred in 16 out of the 1989
cycles (0.8%) included in the three studies reporting either ongoing
pregnancy or live birth rates. Furthermore, although EMT less than
7 mm seemed to be associated with a reduction in live birth rate (OR
0.38), this difference was not statistically significant (95% CI 0.03 to
1.54). In our study, EMT less than 7.0 mm occurred in 8.5% (n = 284)
of all cycles and was associated with a decrease in live birth rate,
results that are more in line with the conclusions of at least three
recently published studies with a higher incidence of EMT less than
7 mm as well (Holden et al., 2017; Ma et al., 2017; Yuan et al., 2016).
Another potential explanation that may explain the differences between
the results of Kasius et al. (2014) and the studies that followed (beyond
the six- to 10-fold increase in incidence of EMT <7 mm) may be the
fact that ongoing pregnancy rates and live birth rate were consid-
ered together in this meta-analysis, a decision that could have
produced significant residual confounding. For this reason, an updated
meta-analysis integrating these most recent results is currently under












Ovarian response and embryo production
Oocytes retrieved
Median (IQR) 8 (5–13) 9 (5–113) 9 (6–113) 8 (5–112) 8 (6–113) NS
Useable embryos
Median (IQR) 2 (2–15) 3 (2–14) 3 (2–14) 3 (2–14) 3 (2–15) NS
Embryo transfer
Number of embryos transferred,
n (%)
Single 179 (63.0) 570 (62.1) 690 (59.5) 388 (58.8) 197 (59.9) NS
Multiple 105 (37.0) 348 (37.9) 469 (40.5) 272 (41.2) 132 (40.1)
Embryo developmental stage at
transfer, n (%)
Cleavage 172 (60.6) 505 (55.0) 661 (57.0) 403 (61.1) 205 (62.3) NS
Blastocyst 112 (39.4) 413 (45.0) 498 (43.0) 257 (38.9) 124 (37.7)
Quality of best embryo transferred,
n (%)
1 186 (65.5) 637 (69.4) 804 (69.4) 468 (70.9) 245 (74.5) NS
2 81 (28.5) 234 (25.5) 307 (26.5) 168 (25.5) 64 (19.5)
3–14 17 (6.0) 47 (5.1) 48 (4.1) 24 (3.6) 20 (6.1%)
Pregnancy and neonatal outcome
Pregnancy outcome, n (%)
Positive pregnancy test 92 (32.4) 415 (45.2) 567 (48.9) 341 (51.7) 173 (52.6) <0.001
Clinical pregnancy 82 (28.9) 374 (40.7) 530 (45.7) 318 (48.2) 160 (48.6) <0.001
Clinical miscarriage 18/82 (22.0) 85/374 (22.7) 112/530 (21.1) 70/318 (22.0) 48/160 (30.0) NS
Ectopic pregnancy 2/82 (2.4) 10/374 (2.7) 8/530 (1.5) 4/318 (1.3) 3/160 (1.9) NS
Stillbirths/elective terminations 0/82 (0) 1/82 (0.3) 2/530 (0.4) 2/318 (0.6) 0/160 (0) NS
Live birth 62 (21.8) 278 (30.3) 408 (35.2) 242 (36.7) 109 (33.1) 0.001
Singleton 60 (96.8) 255 (91.7) 352 (86.3) 208 (85.9) 91 (83.5) 0.027
Twin/triplet 2 (3.2) 23 (8.3) 56 (13.7) 34 (14.1) 18 (16.5)
Gestational age (days)b
Median (IQR) 275 (269–1282) 275 (268–1281) 276 (268–1282) 276 (269–1281) 276 (270–1281) NS
Preterm birth (<37 weeks), n (%) 7/60 (11.7) 27/248 (10.9) 39/344 (11.3) 14/201 (7.) 4/86 (4.7) NS
Birth weight z-scoreb
Mean (SD) −10.7 ± 1.1 −10.4 ± 1.0 −10.3 ± 1.0 −10.3 ± 1.1 −10.4 ± 1.0 0.020
Birth weight (g)b
Median (IQR) 3135 (2845–13350) 3250 (2898–13550) 3270 (2950–13670) 3330 (3010–13650) 3275 (3090–13548) NS
Low birth weight (<2500 g), n (%) 4/60 (6.7) 24/248 (9.7) 25/344 (7.3) 18/201 (9.0) 3/86 (3.5) NS
Sex of newborn, n (%)b
Female 30/60 (50.0) 126/248 (50.8) 178/344 (51.7) 99/201 (49.3) 46/86 (53.5) NS
Male 30/60 (50.0) 122/248 (49.2) 166/344 (48.3) 102/201 (50.7) 40/86 (46.5)
a Comparisons among groups of endometrial thickness made using univariable generalized estimating equation regression analysis accounting for the clus-
tering of cycles undergone by the same women.
b Data presented only for singleton deliveries with known date of delivery, birth weight and newborn sex (n = 939).
IQR, interquartile range; NS, non-significant.
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way to further understand the discrepancies among the pooled and
un-pooled data thus far.
The most common causes for a thin endometrium are either an
iatrogenic event, e.g. Asherman’s syndrome, infection, e.g. with sec-
ondary adhesion development, or exogenous hormonal therapy, e.g.
use of oral combined contraceptives, prolonged progesterone therapy
and use of clomiphene citrate (Lebovitz and Orvieto, 2014; Senturk
and Erel, 2008). A thin endometrium, however, can still occur in other
cases for reasons that are less well understood, e.g. high blood flow
impedance of the uterine radial arteries (Miwa et al., 2009). Early
studies demonstrated that, after ovulation, the spiral arteries con-
strict preemptively to diminish blood flow to the functional layer
(Rossman and Bartelmez, 1957). Nevertheless, a thinned or absent
functional layer may subject the embryo to higher vascularity from
the basal endometrium, which might explain the reduction of im-
plantation caused by elevated oxygen tension and the production of
detrimental reactive oxygen species (Catt and Henman, 2000; Yang
et al., 1998).
Given the mounting evidence of a detrimental effect of a thin en-
dometrial lining during IVF, multiple researchers have proposed
potential treatment alternatives, including alternative routes for oes-
tradiol administration (Tourgeman et al., 2001) and adjuvant sildenafil
(Check et al., 2004; Takasaki et al., 2010), pentoxifylline (Ledee-Bataille
et al., 2004; Letur-Konirsch and Delanian, 2003) and granulocyte
colony-stimulating factor treatment (Kunicki et al., 2017; Li et al., 2017;
Xu et al., 2015), all with controversial results. More recently, stem-
cell transplantation has also been shown as a promising alternative
(Kunicki et al., 2017; Li et al., 2017; Xu et al., 2015). Future prospec-
tive trials may assist physicians in understanding whether postponing
the embryo transfer to a subsequent frozen embryo transfer cycle
so that further investigations can be carried out e.g. a hysteros-
copy, and an alternative treatment used at a later stage, may ultimately
optimize assisted reproduction technique outcome.
In contrast to previously published studies (Amir et al., 2007; Gurbuz
et al., 2004), we found no association between female age and EMT.
This difference in results may be explained by the fact that our study
included only women aged younger than 40 years, who were the only
group in which the effect of age seemed to become relevant for EMT
in the previously mentioned studies. For this reason, we would rec-
ommend against extrapolating our results beyond the age group that
was included.
Our study also evaluated the potential effect of BMI on EMT. Pre-
viously published studies found an association between obesity and
hyperinsulinemic state, which may promote the ovarian production
of androgens and peripheral conversion of oestrogen in adipocytes
(Rachon and Teede, 2010). Furthermore, a relationship between obesity
and abnormal endometrial receptivity has also been described (Bellver
et al., 2007; Dessolle et al., 2009; DeUgarte et al., 2010), positing that
obese women, despite having higher EMTs, might also have im-
paired implantation. Corroborating previous data (Souter et al., 2011),
Figure 1 – Predicted endometrial thickness (EMT) according to (A) the duration of ovarian stimulation and (B) late-follicular oestradiol. The
figure depicts the predicted mean EMT (teal line) and 95% CI (teal area); The full regression model is detailed in Supplementary Table S1.
(For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
Figure 2 – Predicted live birth rates according to endometrial
thickness. The figure depicts the predicted live birth rates after
multivariable regression analysis adding endometrial thickness
(EMT) as either a continuous (model 1, teal solid line and area for
predicted liv birth rate and 95% CI) or categorical-ordinal (model
2, blue dashed line) variable; the full regression models are
detailed in Supplementary Table S2. (For interpretation of the
references to colour in this figure legend, the reader is referred to
the Web version of this article.)
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we also found that BMI was linearly associated with EMT
(Supplementary Table S1). This discrete effect of BMI on EMT did not
seem to translate into an increase in live birth rates. In fact, BMI was
not associated with live birth rates in this sample of GnRH antago-
nist suppressed cycles, an observation that was also confirmed by a
recent randomized controlled trial (Toftager et al., 2017).
Late-follicular phase oestradiol levels were also shown to have
an independent effect on EMT in our study. Although previous re-
searchers have also established a positive linear correlation between
oestradiol levels and EMT (Zhang et al., 2005), this finding was con-
tradicted by a study including 2339 cycles using various stimulation
protocols, which mentioned that oestradiol levels above 1000 pg/ml
had no effect on EMT (Amir et al., 2007). We report a similar finding
to this latter study, but in a larger sample set. In addition, late-
follicular oestradiol over 3000 pg/ml seemed also to result in a discrete
but statistically significant negative effect on live birth (Supplementary
Table S2 and Figure 3A), which is also in accordance with previous
research (Kolibianakis and Devroey, 2002; Marchini et al., 1991). Spe-
cifically, these investigators have speculated that high oestradiol levels
may alter the expression of progesterone receptors, potentially
triggering an advancement in endometrial maturation despite the
presence of otherwise normal pre-ovulatory circulating progester-
one levels.
A longstanding debate on the importance of progesterone in fresh
embryo transfer cycles has taken place. According to studies in women
undergoing oocyte donation, progesterone plays a crucial role in
endometrial receptivity, but not in oocyte quality (Check et al., 1994,
2010; Hofmann et al., 1993; Legro et al., 1993; Melo et al., 2006;
Shulman et al., 1996). To the best of our knowledge, this is the first
study relating circulating late-follicular levels of progesterone with
EMT. Elevated progesterone (mostly defined as a HCG-day proges-
terone >1.5 ng/ml) may decrease the thickness of the endometrium
by inducing early secretory endometrial transformation, which may
anticipate the window of implantation and have a negative effect on
live birth rates (Bosch et al., 2010; Healy et al., 2017; Hill et al., 2017;
Santos-Ribeiro et al., 2014; Venetis et al., 2016).
Endometrial thickness was associated with a statistically signifi-
cant decrease in birthweight z-scores, albeit not clinically translatable
to an increase in cases of LBW. This contradictory finding may po-
tentially be caused by the limited size of the singleton live birth sample
subset (Table 3). As z-scores account for the differences in gesta-
tional age and new-born gender, this more robust statistical approach
Figure 3 – Surface plots of the relationship between the effects of (A) endometrial thickness (EMT) and late-follicular oestradiol and (B)
progesterone on live birth. Predicted live birth probabilities derived from the regression model detailed in Supplementary Table S2
(model 1).
Table 3 – Endometrial thickness regression estimates for neonatal outcomes in singleton pregnancies (n = 939).a
Modelb Model 2
Best-fit FP Coefficient (95% CI) <7.0 mm 7.0–8.9 mm 9.0–10.9 mm 11.0–12.9 mm ≥13.0 mm
Gestational age (days)
Linear 0.32 (−0.08 to 0.73) −0.96 (−4.76 to 2.84) 0.13 (−2.12 to 2.39) Reference 0.69 (−1.71 to 3.10) 2.26 (−1.02 to 5.55)
Preterm birth (<37 weeks, n = 91)
Linear −0.09 (−0.07 to 0.03) 0.06 (−0.82 to 0.93) −0.09 (−0.62 to 0.45) Reference −0.46 (−1.10 to 0.19) −0.91 (−1.98 to 0.16)
Birth weight z-scorec
FP1 (−2) −0.11 (−020 to −0.02)d −0.40 (−0.69 to −0.12)e −0.13 (−0.30 to 0.03) Reference −0.08 (−0.27 to 0.10) −0.18 (−0.42 to 0.05)
Low birth weight (<2500 g, n = 74)
Linear −0.07 (−0.19 to 0.04) −0.11 (−1.22 to 0.99) 0.26 (−0.33 to 0.86) Reference 0.24 (−0.40 to 0.88) −0.74 (−1.98 to 0.49)
a Multivariable generalized estimating equation regression analyses (adjusted for female age, body mass index, parity and late-follicular oestradiol and pro-
gesterone) with endometrial thickness (EMT) and other continuous variables added either as best-fitting fractional polynomials (FPs) (model 1, in which the
best-fit FP and regression coefficients (95% CI) for EMT are presented here) or ordinal categories (model 2, presenting here the regression coefficients
[95% CI] for EMT).
b The FP of the variable EMT was scaled at x
10
.
c Plotted in Figure 4.
d P = 0.017.
e P = 0.006.
FP1, first-degree fractional polynomial (power).
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results in a more accurate assessment of the association between
EMT and birthweight. This finding is also relatively unexplored, with
Chung et al. (2006) also concluding in their small subgroup analysis
of singletons that an EMT less than 10 mm had an almost threefold
increased risk of LBW. Both studies highlight the potential effect of
a thin endometrium beyond live birth rates, with birth weight being
hindered by possible abnormal trophoblastic invasion (Chung et al.,
2006). These results, however, require further confirmation in larger
studies.
Strengths and limitations
The main strengths of our study are the large sample size and the
inclusion of information on late-follicular endocrine profile to better
understand the relationship between EMT, live birth and neonatal out-
comes. This allowed for a better estimation of the potential value of
EMT in modern-day medicine, in which combined transvaginal ul-
trasound and serum hormonal monitoring during ovarian stimulation
have prevailed in most centres. This study also has limitations beyond
its retrospective nature that need to be addressed. First, given the
previous evidence of a potential hindering effect of thin EMT, we can
assume that, in some patients, deferring their embryo transfer may
have been proposed to ensue further investigation. In a previous study
from our centre, an EMT below 7 mm was the indication for the use
of the ‘freeze-all’ strategy in about 10% of all cases (Santos-Ribeiro
et al., 2016). This presents a risk for selection bias, which may have
potentially underestimated the incidence of thin EMT and the effect
of thin EMT on the studied outcomes. Furthermore, although we ex-
cluded all women with intrauterine abnormalities visible on either
ultrasound or hysteroscopy, one could argue that some patients could
still have undiagnosed endometrial disease, given that we do not rou-
tinely carry out hysteroscopies before IVF. Nonetheless, we would
argue that the likelihood that this could play a major role is minimal,
given that two recent randomized controlled trials showed that routine
hysteroscopy before IVF does not affect pregnancy outcome (El-Toukhy
et al., 2016; Smit et al., 2016).
In Supplementary Table S2, the clinical usefulness of the cut-
offs in model 2 are presented; however, we would still advise caution
in the application of these limits in all instances given the risks of
residual confounding after ordinal categorization of a continuous
variable. Given the relatively large size (over 200 patients) of all our
study subgroups, one would except this risk to be relatively small.
In the neonatal outcomes analysis, the relatively small subset of
cases included resulted in large confidence intervals. Furthermore,
as we could not adjust for other potential confounders for preterm
delivery (such as history of preterm delivery) or LBW (namely, female
smoking), our results should be interpreted with caution and require
confirmation in future studies.
Implications for clinical practice and conclusion
The present study adds information on the value of EMT as a non-
invasive parameter to infer on endometrial receptivity, a matter that
is not yet universally acknowledged. Taken together, our findings
suggest that the prognostic value of EMT should still be considered
in clinical practice for both live birth and neonatal birthweight. Tai-
loring the ideal timing of embryo transfer, i.e., in the same fresh cycle
or in a subsequent frozen embryo transfer cycle according to EMT,
could be further optimized when the late follicular hormonal profile
is also considered.
Appendix: Supplementary material
Supplementary data to this article can be found online at
doi:10.1016/j.rbmo.2017.12.016.
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